TY - JOUR
T1 - Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation
AU - Hochberg, Ze'ev
AU - Van Lieburg, Anita
AU - Even, Lea
AU - Brenner, Benjamin
AU - Lanir, Naomi
AU - Van Oost, Bernard A.
AU - Knoers, Nine V.A.M.
PY - 1997/2
Y1 - 1997/2
N2 - Vasopressin V2 receptors, expressed from an x-chromosomal gene, are involved in antidiuresis, but also in release of coagulation factor VIII and von Willebrand factor (vWF). The present study describes autosomal recessive nephrogenic diabetes insipidus (NDI) in a large cluster of patients in Israel's Lower-Galilee. Evidence for an intact V2 receptor was concluded by their normal increase in factor VIII and vWF after desmopressin infusion. Thus, in these patients a defect in the pathway beyond the V2 receptor was suspected. The recent cloning of the human Aquaporin-2 gene enabled us to test this gene as a candidate for such a postreceptor defect. Direct sequencing of the Aquaporin-2 gene revealed a G298T substitution causing a Gly100Stop nonsense mutation in the third transmembrane region. Because this putative disease-causing mutation was identified in index patients of different families, we suggest that all patients are descendants of a common ancestor. Thus, this new entity is characterized by an autosomal recessive NDI. The differential response of clotting factors and urine osmolality to desmopressin may provide a simple tool for clinical diagnosis of a V2- postreceptor defect. The early stop-codon of Aquaporin 2 results in complete resistance to vasopressin antidiuretic effect.
AB - Vasopressin V2 receptors, expressed from an x-chromosomal gene, are involved in antidiuresis, but also in release of coagulation factor VIII and von Willebrand factor (vWF). The present study describes autosomal recessive nephrogenic diabetes insipidus (NDI) in a large cluster of patients in Israel's Lower-Galilee. Evidence for an intact V2 receptor was concluded by their normal increase in factor VIII and vWF after desmopressin infusion. Thus, in these patients a defect in the pathway beyond the V2 receptor was suspected. The recent cloning of the human Aquaporin-2 gene enabled us to test this gene as a candidate for such a postreceptor defect. Direct sequencing of the Aquaporin-2 gene revealed a G298T substitution causing a Gly100Stop nonsense mutation in the third transmembrane region. Because this putative disease-causing mutation was identified in index patients of different families, we suggest that all patients are descendants of a common ancestor. Thus, this new entity is characterized by an autosomal recessive NDI. The differential response of clotting factors and urine osmolality to desmopressin may provide a simple tool for clinical diagnosis of a V2- postreceptor defect. The early stop-codon of Aquaporin 2 results in complete resistance to vasopressin antidiuretic effect.
UR - http://www.scopus.com/inward/record.url?scp=0031026530&partnerID=8YFLogxK
U2 - 10.1210/jc.82.2.686
DO - 10.1210/jc.82.2.686
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 9024277
AN - SCOPUS:0031026530
SN - 0021-972X
VL - 82
SP - 686
EP - 689
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 2
ER -